HORMONET: a phase II trial of tamoxifen for estrogen/progesterone receptor-positive neuroendocrine tumors.
Milton J BarrosJonathan StrosbergTaymeyah Al-ToubahVictor Hugo Fonseca de JesusLais DurantCelso A MelloTiago C FelisminoLouise De BrotRodrigo G TaboadaMauro D DonadioRachel Simões Pimenta RiechelmannPublished in: Therapeutic advances in medical oncology (2023)
NCT03870399.